Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT00412061 at 2026-07-30T21:54:46.554Z. Its registry update date was 2014-11-21, and PeptideScanner's reviewed identity mapping was octreotide.↗
PeptideScanner retained ClinicalTrials.gov record NCT00412061 at 2026-07-30T21:54:46.554Z. Its registry update date was 2014-11-21, and PeptideScanner's reviewed identity mapping was octreotide. 1
This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1
Complete submitted registry timeline
ClinicalTrials.gov lists these public versions with submitted dates from December 14, 2006 through November 11, 2014. Each entry links to the exact public source version and reports only the source-declared status, study type, dates, and changed-module labels.
Source-declared changed modules: None listed for this version
Source-declared changed modules: Eligibility, Study Design, Study Status
Source-declared changed modules: Contacts/Locations, References, Study Status
Source-declared changed modules: Contacts/Locations, Study Design, Study Identification, Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Contacts/Locations, Sponsor/Collaborators, Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Arms and Interventions, Contacts/Locations, Outcome Measures, Study Design, Study Status
Source-declared changed modules: References, Study Identification, Study Status
Source-declared changed modules: References, Study Status
Source-declared changed modules: Contacts/Locations, Study Status
Source-declared changed modules: Adverse Events, Arms and Interventions, Baseline Characteristics, Eligibility, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Sponsor/Collaborators, Study Description, Study Design, Study Status
Source-declared changed modules: Outcome Measures, Outcome Measures (Results), Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Arms and Interventions, Contacts/Locations, Study Design, Study Identification, Study Status
Source-declared changed modules: Baseline Characteristics, Study Status
Source-declared changed modules: Adverse Events, Contacts/Locations, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Design, Study Status
Source-declared changed modules: Outcome Measures (Results), Study Status
ClinicalTrials.gov · Official source · Source checked August 9, 2026